<DOC>
	<DOCNO>NCT02367976</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety rh-prouk pharmacoinvasive therapy ST Elevated Myocardial Infarctions patient , design multicenter , active control , single blind study . The primary endpoint ass coronary recanalization 90 minute thrombolysis . The secondary endpoint evaluate mortality rate day 30 .</brief_summary>
	<brief_title>Efficacy Safety Prouk STEMI Patients China</brief_title>
	<detailed_description>The purpose study evaluate efficacy safety rh-prouk pharmacoinvasive therapy ST Elevated Myocardial Infarctions patient , design multicenter , active control , single blind study . The primary endpoint ass percentage patient achieve coronary recanalization 90 minute thrombolysis . The secondary endpoint evaluate mortality rate day 30 .</detailed_description>
	<criteria>Chest pain &gt; 30 minute , &lt; 12 hour Expected PCI related delay time &gt; 60 minute , OR Door To Balloon time &gt; 90 minute ECG confirm STEMI . Age : 1875 year old Weight &lt; =85Kg Consent participate study Exclusion Criteria Evidence cardiac rupture ; ECG : new leave bundle branch block ; Thrombolysis contradiction Any history central nervous system damage ( i.e . neoplasm , aneurysm , intracranial spinal surgery ) recent trauma head cranium ( i.e . &lt; 3 month ) ; Active bleeding know bleed disorder . Recent administration i.v . s.c. anticoagulation within 12 hour includingunfractionated heparin , enoxaparin and/or bivalirudin current use oral anticoagulation ( warfarin coumadin ) ; Uncontrolled hypertension , define single blood pressure measurement ≥ 180/110 mm Hg ( systolic BP ≥ 180 mm Hg and/or diastolic BP ≥ 110 mm Hg ) prior randomisation ; Major surgery , biopsy parenchymal organ , significant trauma within past 2 month ( include trauma associate current myocardial infarction ) ; Prolonged traumatic cardiopulmonary resuscitation ( &gt; 10 minute ) within past 2 Weeks Major surgery pending follow 30 day ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>